Keywords: zenapax, results, boost, pdl, roche, multinational, phase

Zenapax Results Boost PDL And Roche

Article | 07 October 1996

Print This

The results of two multinational Phase III trials evaluating Protein Design Labs' Zenapax (dacliximab) for the prevention of acute graft ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in